Clinical and Translational Radiation Oncology

Top Research Topics at Clinical and Translational Radiation Oncology?

Clinical and Translational Radiation Oncology focuses on Radiation therapy, Internal medicine, Radiology, Oncology and Nuclear medicine. It is mostly focused on Radiation therapy, specifically Head and neck cancer. The journal centers on topics in Head and neck cancer, with a focus on Head and neck squamous-cell carcinoma.

The work on Internal medicine addressed in Clinical and Translational Radiation Oncology expands to the thematically related Gastroenterology. The Radiology works featured in it incorporate elements from Stage (cooking), Colorectal cancer and Cohort. Pathology and Immunotherapy are some topics wherein Oncology research discussed in the journal have an impact.

The journal focuses on Nuclear medicine but the discussions also offer insight into other areas such as Breast cancer, Radiation treatment planning, Planning target volume and Proton therapy. Prostate cancer research featured in the journal incorporates concerns from various other topics such as Prostate, Brachytherapy, Genitourinary system and Urology. It focused on Lung cancer research but expanded to cover Lung.

• Radiation therapy (56.87%)
• Internal medicine (29.64%)
• Radiology (26.02%)

What are the most cited papers published in the journal?

• The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies (208 citations)
• Adaptive radiotherapy: The Elekta Unity MR-linac concept. (138 citations)
• COVID-19: Global Radiation Oncology’s Targeted Response for Pandemic Preparedness (125 citations)

Research areas of the most cited articles at Clinical and Translational Radiation Oncology:

The most cited publications investigate areas of study like Radiation therapy, Internal medicine, Oncology, Medical physics and Cancer. The most cited publications facilitate discussions on Radiation therapy that incorporate concepts from other fields like Colorectal cancer and Magnetic resonance imaging. The most cited publications address concerns in Medical physics which are intertwined with other disciplines, such as Radiation treatment planning, External beam radiotherapy, Workflow and Image-guided radiation therapy.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Radiation therapy

The previous edition focused in particular on these issues:

Clinical and Translational Radiation Oncology primarily tackles Radiation therapy, Internal medicine, Radiology, Nuclear medicine and Oncology. The Radiation therapy works, particularly on Head and neck cancer are tackled in the journal. Clinical and Translational Radiation Oncology deals with Internal medicine in conjunction with Gastroenterology and similar fields in Univariate analysis, Progression-free survival and Chemoradiotherapy.

Some problems in Radiology that were presented in it overlapped with concepts under Bladder cancer, Prospective cohort study and Primary tumor. While Nuclear medicine is the key highlight in it, it also covered some subjects on Planning target volume and Flank. The concepts on Prostate cancer presented in Clinical and Translational Radiation Oncology can also apply to other research fields, including Prostate, Brachytherapy, Urology, Toxicity and Genitourinary system.

The most cited articles from the last journal are:

• Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy. (7 citations)
• Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance. (5 citations)
• Selection criteria for early breast cancer patients in the DBCG proton trial - The randomised phase III trial strategy. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Clinical and Translational Radiation Oncology (based on the number of publications) are:

• Daniel Zips (13 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Clifton D. Fuller (13 papers) published 5 papers at the last edition, 4 more than at the previous edition,
• David I. Rosenthal (11 papers) published 3 papers at the last edition, 1 more than at the previous edition,
• Abdallah S.R. Mohamed (11 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Esther G.C. Troost (10 papers) published 3 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical and Translational Radiation Oncology (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (39 papers) published 7 papers at the last edition the same number as at the previous edition,
• The Royal Marsden NHS Foundation Trust (22 papers) published 10 papers at the last edition, 6 more than at the previous edition,
• Utrecht University (21 papers) published 12 papers at the last edition, 10 more than at the previous edition,
• German Cancer Research Center (18 papers) published 5 papers at the last edition, 2 more than at the previous edition,
• University of Tübingen (18 papers) published 5 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.55% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 41.90% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.48% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.14% of all publications and 30.48% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Paths in Clinical and Translational Radiation Oncology

Research and practice in Clinical and Translational Radiation Oncology can lead to a variety of career paths. Many people who work in this field have a medical background, often with a specialization such as Radiology, Oncology or Nuclear Medicine. However, opportunities for non-clinicians are expanding as well. Radiation oncologists, medical physicists and radiation therapists make up the main group of professionals in this sector. To enter this field, one usually has to complete medical school and a radiology residency, followed by a one to two years' fellowship in radiation oncology. For those whose passion is nursing, a beneficial career path could be becoming an oncology nurse, specializing in radiation therapy. They provide care for cancer patients undergoing radiation treatment, monitor patient’s physical conditions, and manage radiation side effects. If you desire to start a nursing career in Arkansas for instance, you can follow this guide on how to become a nurse in Arkansas . Medical physicists also play a critical role in radiation oncology. They ensure that radiation is used safely and effectively in the treatment of cancer. Medical physicists need a strong foundation in physics and specialized training in radiation therapy. Clinical research in radiation oncology usually requires a doctoral degree in the medical or scientific field. If you are interested in clinical research, keep in mind that besides biological and clinical understanding, mastering statistical methods and data science skills are also highly valuable. In conclusion, a career in Clinical and Translational Radiation Oncology, whether clinical or research focused, offers opportunities to make a significant impact in cancer care and treatment innovations.